{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:04:45Z","timestamp":1787025885719,"version":"build-2736575974"},"reference-count":115,"publisher":"SAGE Publications","issue":"s1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,12,27]]},"DOI":"10.3233\/jad-190851","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T08:19:59Z","timestamp":1573633199000},"page":"S177-S191","source":"Crossref","is-referenced-by-count":14,"title":["Role of Phosphorylated Tau and Glucose Synthase Kinase 3 Beta in Huntington\u2019s Disease Progression"],"prefix":"10.1177","volume":"72","author":[{"given":"Neha","family":"Sawant","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Hemachandra","family":"Reddy","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Texas Tech University Health Sciences Center, Lubbock, TX, USA"},{"name":"Garrison Institute on Aging, Texas Tech University Health Sciences Center, Lubbock, TX, USA"},{"name":"Cell Biology & Biochemistry Department, Texas Tech University Health Sciences Center, Lubbock, TX, USA"},{"name":"Pharmacology & Neuroscience Department, Texas Tech University Health Sciences Center, Lubbock, TX, USA"},{"name":"Neurology Department, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190851_ref1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.58.2.273","article-title":"Progression of symptoms in the early and middle stages of Huntington disease","volume":"58","author":"Kirkwood","year":"2001","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-190851_ref2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrg1686","article-title":"History of genetic disease: The molecular genetics of Huntington disease - a history","volume":"6","author":"Bates","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.3233\/JAD-190851_ref3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: From molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-190851_ref4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fnbeh.2014.00135","article-title":"Mood disorders in Huntington\u2019s disease: From behavior to cellular and molecular mechanisms","volume":"8","author":"Pla","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.3233\/JAD-190851_ref5","first-page":"21","article-title":"Brain imaging and cognitive dysfunctions in Huntington\u2019s disease","volume":"31","author":"Montoya","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.3233\/JAD-190851_ref6","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/mds.26419","article-title":"Factor analysis of the hospital anxiety and depression scale among a Huntington\u2019s disease population","volume":"14","author":"Dale","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-190851_ref7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cortex.2017.07.017","article-title":"Cognitive decline in Huntington\u2019s disease expansion gene carriers","volume":"95","author":"Baake","year":"2017","journal-title":"Cortex"},{"key":"10.3233\/JAD-190851_ref8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington\u2019s disease: A systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-190851_ref9","unstructured":"Huntington G (1872) On chorea. Medical and Surgical Reporter 1872."},{"key":"10.3233\/JAD-190851_ref10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/0972-2327.175425","article-title":"The story of George Huntington and his disease","volume":"19","author":"Bhattacharyya","year":"2016","journal-title":"Ann Indian Acad Neurol"},{"key":"10.3233\/JAD-190851_ref11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/306234a0","article-title":"A polymorphic DNA marker genetically linked to Huntington\u2019s disease","volume":"306","author":"Gusella","year":"1983","journal-title":"Nature"},{"key":"10.3233\/JAD-190851_ref12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.3233\/JAD-190851_ref13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0166-2236(99)01415-0","article-title":"Recent advances in understanding the pathogenesis of Huntington\u2019s disease","volume":"22","author":"Reddy","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-190851_ref14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington\u2019s disease and the striatal medium spiny neuron: Cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JAD-190851_ref15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-190851_ref16","first-page":"1202","article-title":"The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size","volume":"60","author":"Brinkman","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JAD-190851_ref17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-190851_ref18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.3233\/JAD-190851_ref19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-190851_ref20","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.3233\/JAD-190851_ref21","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington\u2019s disease","volume":"21","author":"Laforet","year":"2001","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-190851_ref22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/2510","article-title":"Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA","volume":"20","author":"Reddy","year":"1998","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-190851_ref23","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.drudis.2014.03.020","article-title":"Increased mitochondrial fission and neuronal dysfunction in Huntington\u2019s disease: Implications for molecular inhibitors of excessive mitochondrial fission","volume":"7","author":"Reddy","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.3233\/JAD-190851_ref24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-1-19","article-title":"Multiple pathways contribute to the pathogenesis of Huntington disease","volume":"1","author":"Li","year":"2006","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-190851_ref25","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1093\/hmg\/ddv429","article-title":"Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington\u2019s disease","volume":"24","author":"Manczak","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/hmg\/ddl467","article-title":"Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space","volume":"16","author":"Strehlow","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref27","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","article-title":"Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity","volume":"16","author":"Atwal","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.3233\/JAD-190851_ref29","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1523\/JNEUROSCI.19-03-00964.1999","article-title":"Mutant huntingtin expression in clonal striatal cells: Dissociation of inclusion formation and neuronal survival by caspase inhibition","volume":"3","author":"Kim","year":"1999","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-190851_ref30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease","volume":"3","author":"Cepeda","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-190851_ref31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1044-7431(02)00013-1","article-title":"Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington\u2019s disease","volume":"22","author":"Senatorov","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"10.3233\/JAD-190851_ref32","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190851_ref33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddr475","article-title":"Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease","volume":"21","author":"Shirendeb","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin\u2013protein interactions and the pathogenesis of Huntington\u2019s disease","volume":"3","author":"Li","year":"2004","journal-title":"Trends Genet"},{"key":"10.3233\/JAD-190851_ref35","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","article-title":"Mitochondrial structural and functional dynamics in Huntington\u2019s disease","volume":"61","author":"Reddy","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.3233\/JAD-190851_ref37","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/brain\/aww021","article-title":"Is Huntington\u2019s disease a tauopathy?","volume":"139","author":"Gratuze","year":"2016","journal-title":"Brain"},{"key":"10.3233\/JAD-190851_ref38","doi-asserted-by":"crossref","first-page":"e2206","DOI":"10.1038\/cddis.2016.104","article-title":"GSK-3\u03b2-induced tau pathology drives hippocampal neuronal cell death in Huntington\u2019s disease: Involvement of astrocyte-neuron interactions","volume":"7","author":"L\u2019Episcopo","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.3233\/JAD-190851_ref39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresrev.2010.11.004","article-title":"Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases","volume":"67","author":"Reddy","year":"2011","journal-title":"Brain Res Rev"},{"key":"10.3233\/JAD-190851_ref40","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: Implications for selective neuronal damage","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: Selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190851_ref42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190851_ref43","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism","volume":"14","author":"Seong","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref44","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.3233\/JAD-190851_ref45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.dnarep.2008.09.004","article-title":"Mitochondrial DNA damage is a hallmark of chemically induced and the R6\/2 transgenic model of Huntington\u2019s disease","volume":"8","author":"Acevedo-Torres","year":"2008","journal-title":"DNA Repair"},{"key":"10.3233\/JAD-190851_ref46","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-190851_ref47","first-page":"388","article-title":"Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons","volume":"22","author":"Chang","year":"2006","journal-title":"Dis"},{"key":"10.3233\/JAD-190851_ref48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/hmg\/ddp467","article-title":"Identical oligomeric and fibrillary structures captured from the brains of R6\/2 and knock-in mouse models of Huntington\u2019s disease","volume":"19","author":"Sathasivam","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref49","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nsmb.1570","article-title":"Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism","volume":"16","author":"Thakur","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.3233\/JAD-190851_ref50","doi-asserted-by":"crossref","first-page":"21647","DOI":"10.1074\/jbc.M109.016923","article-title":"Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment","volume":"284","author":"Legleiter","year":"2009","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190851_ref51","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00001756-199707070-00031","article-title":"Fast transport and retrograde movement of huntingtin and HAP 1 in axons","volume":"8","author":"Block-Galarza","year":"1997","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-190851_ref52","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","article-title":"Impaired synaptic plasticity in mice carrying the Huntington\u2019s disease mutation","volume":"8","author":"Usdin","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuroscience.2012.05.043","article-title":"Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington\u2019s disease","volume":"251","author":"Nithianantharajah","year":"2013","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-190851_ref54","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fnmol.2018.00478","article-title":"Altered synaptic vesicle release and Ca2+ influx at single presynaptic terminals of cortical neurons in a knock-in mouse model of Huntington\u2019s disease","volume":"11","author":"Chen","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-190851_ref55","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/hmg\/ddg218","article-title":"Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release","volume":"12","author":"Li","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref56","first-page":"331","article-title":"Tau alteration and neuronal degeneration in tauopathies: Mechanisms and models","volume":"1739","author":"Brandt","year":"2005","journal-title":"Biochem Biophys Acta"},{"key":"10.3233\/JAD-190851_ref57","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainres.2011.07.052","article-title":"Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer\u2019s disease","volume":"1415","author":"Reddy","year":"2011","journal-title":"Brain Res"},{"key":"10.3233\/JAD-190851_ref58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol Rev"},{"key":"10.3233\/JAD-190851_ref59","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-190851_ref60","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.3233\/JAD-190851_ref61","first-page":"271","article-title":"Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2","volume":"387","author":"Neve","year":"1986","journal-title":"Brain Res"},{"key":"10.3233\/JAD-190851_ref62","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/WCO.0000000000000502","article-title":"Update on tauopathies","volume":"30","author":"Lebouvier","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.3233\/JAD-190851_ref63","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00018-016-2351-6","article-title":"Back to the tubule: Microtubule dynamics in Parkinson\u2019s disease","volume":"74","author":"Pellegrini","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-190851_ref64","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: Convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-190851_ref65","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ana.410030616","article-title":"Huntington disease associated with Alzheimer disease","volume":"3","author":"McIntosh","year":"1978","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190851_ref66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1532-5415.1988.tb01807.x","article-title":"The coexistence and differentiation of late onset Huntington\u2019s disease and Alzheimer\u2019s disease. A case report and review of the literature","volume":"36","author":"Moss","year":"1988","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-190851_ref67","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jnnp.48.6.530","article-title":"Late onset of Huntington\u2019s disease","volume":"48","author":"Myers","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-190851_ref68","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s007020050095","article-title":"Alzheimer-type lesions in Huntington\u2019s disease","volume":"105","author":"Jellinger","year":"1998","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-190851_ref69","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.parkreldis.2011.06.010","article-title":"Increased levels of total tau protein in the cerebrospinal fluid in Huntington\u2019s disease","volume":"17","author":"Constantinescu","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-190851_ref70","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/mds.22204","article-title":"Association of corticobasal degeneration and Huntington\u2019s disease: Can tau aggregates protect huntingtin toxicity?","volume":"24","author":"Caparros-Lefebvre","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-190851_ref71","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nm.3617","article-title":"Huntington\u2019s disease is a four-repeat tauopathy with tau nuclear rods","volume":"20","author":"Fern\u00e1ndez-Nogales","year":"2014","journal-title":"Nat Med"},{"key":"10.3233\/JAD-190851_ref72","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients","volume":"125","author":"Wild","year":"2015","journal-title":"J Clin Investig"},{"key":"10.3233\/JAD-190851_ref73","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/brain\/awv107","article-title":"The role of tau in the pathological process and clinical expression of Huntington\u2019s disease","volume":"138","author":"Vuono","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-190851_ref74","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/bpa.12430","article-title":"Faulty splicing and cytoskeleton abnormalities in Huntington\u2019s disease","volume":"26","author":"Fern\u00e1ndez-Nogales","year":"2016","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-190851_ref75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/jnc.13762","article-title":"Is there a role of tau in Huntington\u2019s disease?","volume":"139","author":"Zerr","year":"2016","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-190851_ref76","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/hmg\/ddu421","article-title":"Mutant huntingtin alters tau phosphorylation and subcellular distribution","volume":"24","author":"Blum","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref77","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/hmg\/ddu456","article-title":"Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington\u2019s disease","volume":"24","author":"Gratuze","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref78","doi-asserted-by":"crossref","first-page":"e0172762","DOI":"10.1371\/journal.pone.0172762","article-title":"Tau or neurofilament light-Which is the more suitable biomarker for Huntington\u2019s disease?","volume":"12","author":"Niemel\u00e4","year":"2017","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190851_ref79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jnc.13719","article-title":"Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington\u2019s disease","volume":"139","author":"Rodrigues","year":"2016","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-190851_ref80","doi-asserted-by":"crossref","first-page":"e0163479","DOI":"10.1371\/journal.pone.0163479","article-title":"Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington\u2019s disease","volume":"11","author":"Rodrigues","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190851_ref81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1179069518772380","article-title":"Tau: A common denominator and therapeutic target for neurodegenerative disorders","volume":"12","author":"Maxan","year":"2018","journal-title":"J Exp Neurosci"},{"key":"10.3233\/JAD-190851_ref82","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington\u2019s disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-190851_ref83","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1113\/jphysiol.2012.241018","article-title":". Tonic mGluR5\/CB1-dependent suppression of inhibition as a pathophysiological hallmark in the striatum of mice carrying a mutant form of huntingtin","volume":"591","author":"Dvorzhak","year":"2013","journal-title":"J Physiol"},{"key":"10.3233\/JAD-190851_ref84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J Comp Neurol"},{"key":"10.3233\/JAD-190851_ref85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01697-9","article-title":"Transient increase in total tau but not phospho-tau inhuman cerebrospinal fluid after acute stroke","volume":"297","author":"Hesse","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-190851_ref86","first-page":"194","article-title":"Tau in biofluids - relation to pathology, imaging and clinical features","volume":"43","author":"Zetterberg","year":"2017","journal-title":"Neurobiol"},{"key":"10.3233\/JAD-190851_ref87","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1212\/NXI.0000000000000287","article-title":"Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease","volume":"3","author":"Vinther-Jensen","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.3233\/JAD-190851_ref88","doi-asserted-by":"crossref","first-page":"e0193492","DOI":"10.1371\/journal.pone.0193492","article-title":"Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington\u2019s disease","volume":"13","author":"Niemel\u00e4","year":"2018","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190851_ref89","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington\u2019s disease rating scale: Reliability and consistency","volume":"11","author":"Huntington\u2019s disease study group","year":"1996","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-190851_ref90","first-page":"1121","article-title":"Tau pathology in Huntington\u2019s disease: A brief in vivo PET-imaging report","volume":"31","author":"Giehl","year":"2016","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-190851_ref91","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-190851_ref92","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration","volume":"4","author":"Gendron","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-190851_ref93","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2478\/s13380-012-0032-y","article-title":"Soluble forms of tau are toxic in Alzheimer\u2019s disease","volume":"3","author":"Kopeikina","year":"2012","journal-title":"Transl Neurosci"},{"key":"10.3233\/JAD-190851_ref94","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbadis.2015.12.002","article-title":"Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property","volume":"1862","author":"Liu","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-190851_ref95","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1016\/j.febslet.2006.09.060","article-title":"Regulation of phosphorylation of Tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level","volume":"580","author":"Sengupta","year":"2006","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-190851_ref96","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2019-splice-site mutations in tau with the inherited dementia FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"key":"10.3233\/JAD-190851_ref97","first-page":"3","article-title":"Tau exon 10 alternative splicing and tauopathies","volume":"10","author":"Liu","year":"2008","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-190851_ref98","doi-asserted-by":"crossref","first-page":"30497","DOI":"10.1074\/jbc.M112.355412","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine\/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion","volume":"287","author":"Yin","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190851_ref99","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bpa.12387","article-title":"MAP2 splicing is altered in Huntington\u2019s disease","volume":"27","author":"Cabrera","year":"2017","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-190851_ref100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/gb-2004-6-1-204","article-title":"The MAP2\/Tau family of microtubule associated proteins","volume":"6","author":"Dehmelt","year":"2005","journal-title":"Genome Biol"},{"key":"10.3233\/JAD-190851_ref101","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0301-0082(99)00046-5","article-title":"Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function","volume":"61","author":"S\u00e1nchez","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-190851_ref102","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/hdy.2008.70","article-title":"H1 tau haplotype-related genomic variation at 17q21.3 as an Asian heritage of the European Gypsy population","volume":"101","author":"Almos","year":"2008","journal-title":"Heredity"},{"key":"10.3233\/JAD-190851_ref103","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1042\/BST0330582","article-title":"Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens","volume":"33","author":"Hardy","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-190851_ref104","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-015-0025-8","article-title":"Regulation of human MAPT gene expression","volume":"10","author":"Caillet-Boudin","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-190851_ref105","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JAD-190851_ref106","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mcn.2017.01.005","article-title":"The protein serine\/threonine phosphatases PP2A, PP1 and calcineurin: A triple threat in the regulation of the neuronal cytoskeleton","volume":"84","author":"Hoffman","year":"2017","journal-title":"Mol Cell Neurosci"},{"key":"10.3233\/JAD-190851_ref107","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2009.08.012","article-title":"Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington\u2019s disease: Role in excitotoxicity","volume":"36","author":"Xifro","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-190851_ref108","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington\u2019s disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref109","doi-asserted-by":"crossref","first-page":"e24467","DOI":"10.1371\/journal.pone.0024467","article-title":"Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington\u2019s disease transgenic mice","volume":"6","author":"Rajput","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190851_ref110","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1111\/j.1460-9568.2007.05955.x","article-title":"Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation","volume":"26","author":"Liu","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JAD-190851_ref111","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0960-9822(00)00246-3","article-title":"Alzheimer\u2019s disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells","volume":"4","author":"Lovestone","year":"1994","journal-title":"Curr Biol"},{"key":"10.3233\/JAD-190851_ref112","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.celrep.2018.04.045","article-title":"GSK3\u03b2 regulates brain energy metabolism","volume":"23","author":"Martin","year":"2018","journal-title":"Cell Rep"},{"key":"10.3233\/JAD-190851_ref113","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11515-012-1222-2","article-title":"The role of GSK3beta in the development of the central nervous system","volume":"7","author":"Luo","year":"2012","journal-title":"Front Biol (Beijing)"},{"key":"10.3233\/JAD-190851_ref114","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1093\/hmg\/ddu119","article-title":"Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington\u2019s disease affected brain","volume":"23","author":"Lim","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-190851_ref115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2013.10.001","article-title":"Glycogen synthase kinase-3 reduces acetylcholine level in striatum via disturbing cellular distribution of choline acetyltransferase in cholinergic interneurons in rats","volume":"255","author":"Zhao","year":"2013","journal-title":"Neuroscience"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:11Z","timestamp":1777370831000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190851"}},"subtitle":[],"editor":[{"given":"P. Hemachandra","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":115,"journal-issue":{"issue":"s1"},"URL":"https:\/\/doi.org\/10.3233\/jad-190851","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,27]]}}}